Paper36768202
Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
Boisclair C and 4 others. Int J Mol Sci, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach. Papers, record 36768202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768202
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Neoplasms | Major topic |
| Osteosarcoma | Major topic |
| Animals | |
| Dogs | |
| Humans | |
| Protein Binding | |
| Receptor, IGF Type 2 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| WCVM425613 | Western College of Veterinary Medicine Companion Animal Health Fund | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25998714 | Radioimmunotherapy of human tumours. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/25998714 | PubMed |
| 2 | 31546999 | Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar. | Pharmaceuticals (Basel) | 2019 | https://conductscience.org/library/papers/31546999 | PubMed |
| 3 | 31442327 | Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases. | Prostate | 2019 | https://conductscience.org/library/papers/31442327 | PubMed |
| 4 | 19122062 | Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. | J Am Anim Hosp Assoc | 2009 | https://conductscience.org/library/papers/19122062 | PubMed |
| 5 | 27744117 | Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). | Nucl Med Biol | 2016 | https://conductscience.org/library/papers/27744117 | PubMed |
| 6 | 8691094 | Involvement of IGF-II in human cancer. | J Endocrinol | 1996 | https://conductscience.org/library/papers/8691094 | PubMed |
| 7 | 28966355 | Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma. | Can Vet J | 2017 | https://conductscience.org/library/papers/28966355 | PubMed |
| 8 | 18046459 | Structure and functional analysis of the IGF-II/IGF2R interaction. | EMBO J | 2008 | https://conductscience.org/library/papers/18046459 | PubMed |
| 9 | 28477425 | Outcome and complications in dogs with appendicular primary bone tumors treated with stereotactic radiotherapy and concurrent surgical stabilization. | Vet Surg | 2017 | https://conductscience.org/library/papers/28477425 | PubMed |
| 10 | 22587466 | Prognostic factors in canine appendicular osteosarcoma - a meta-analysis. | BMC Vet Res | 2012 | https://conductscience.org/library/papers/22587466 | PubMed |
| 11 | 29284372 | Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care. | Vet Pathol | 2018 | https://conductscience.org/library/papers/29284372 | PubMed |
| 12 | 30768736 | Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma. | J Vet Intern Med | 2019 | https://conductscience.org/library/papers/30768736 | PubMed |
| 13 | 29065898 | Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. | Acta Vet Scand | 2017 | https://conductscience.org/library/papers/29065898 | PubMed |
| 14 | 27776176 | Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma. | PLoS One | 2016 | https://conductscience.org/library/papers/27776176 | PubMed |
| 15 | 8679270 | Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach. | Acta Oncol | 1996 | https://conductscience.org/library/papers/8679270 | PubMed |
| 16 | 1577656 | Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). | J Am Vet Med Assoc | 1992 | https://conductscience.org/library/papers/1577656 | PubMed |
| 17 | 30409432 | Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/30409432 | PubMed |
| 18 | 21751203 | Cell surface receptor expression patterns in osteosarcoma. | Cancer | 2012 | https://conductscience.org/library/papers/21751203 | PubMed |
| 19 | 9825475 | Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance. | Yale J Biol Med | 1997 | https://conductscience.org/library/papers/9825475 | PubMed |
| 20 | 20889358 | Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. | Vet J | 2011 | https://conductscience.org/library/papers/20889358 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39752109 | Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges. | Arch Pharm Res | 2025 | https://conductscience.org/library/papers/39752109 | PubMed |
| 38686047 | Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1α/HK2 and SLC7A11 pathway. | Oncol Res | 2024 | https://conductscience.org/library/papers/38686047 | PubMed |
| 38612282 | The Expression Levels of CD20 as a Prognostic Value in Feline B-Cell Nasal Lymphoma: A Pilot Study. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/38612282 | PubMed |
| 37513891 | Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37513891 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IGF2 | 3481 | PubTator's text mining | https://conductscience.org/library/genes/3481 | NCBI Gene |
| IGF2R | 3482 | PubTator's text mining | https://conductscience.org/library/genes/3482 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| MCAM | 4162 | PubTator's text mining | https://conductscience.org/library/genes/4162 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768202
GET https://conductscience.org/api/papers/v1/36768202/references?page=2